These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9818779)

  • 21. Is the incidence of esophageal adenocarcinomas in patients with Barrett's esophagus really overestimated?
    Younes M
    Gastroenterology; 2005 Dec; 129(6):2125-6; author reply 2126. PubMed ID: 16344087
    [No Abstract]   [Full Text] [Related]  

  • 22. Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?
    Fitzgerald RC
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i21-6. PubMed ID: 15711004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology?
    Prach AT; MacDonald TA; Hopwood DA; Johnston DA
    Lancet; 1997 Sep; 350(9082):933. PubMed ID: 9314878
    [No Abstract]   [Full Text] [Related]  

  • 24. Cancer incidence in Barrett's esophagus: does it really matter, and who's counting anyway?
    Corley DA
    Gastrointest Endosc; 2008 Mar; 67(3):399-401. PubMed ID: 18294502
    [No Abstract]   [Full Text] [Related]  

  • 25. Barrett's columnar-lined oesophagus: demographic and lifestyle associations and adenocarcinoma risk.
    Gatenby PA; Caygill CP; Ramus JR; Charlett A; Watson A
    Dig Dis Sci; 2008 May; 53(5):1175-85. PubMed ID: 17939050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rising incidence of clinically evident Barrett's oesophagus in The Netherlands: a nation-wide registry of pathology reports.
    Post PN; Siersema PD; Van Dekken H
    Scand J Gastroenterol; 2007 Jan; 42(1):17-22. PubMed ID: 17190757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin is not chemoprotective for Barrett's adenocarcinoma of the oesophagus in multicentre cohort.
    Gatenby PA; Ramus JR; Caygill CP; Winslet MC; Watson A
    Eur J Cancer Prev; 2009 Sep; 18(5):381-4. PubMed ID: 19620873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
    Incarbone R; Bonavina L; Bassi F; Peracchia A
    Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer risk in Barrett's oesophagus.
    Dias Pereira A; Suspiro A; Chaves P
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study.
    de Jonge PJ; van Blankenstein M; Looman CW; Casparie MK; Meijer GA; Kuipers EJ
    Gut; 2010 Aug; 59(8):1030-6. PubMed ID: 20639249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoscopic follow-up and management of Barrett's esophagus in relation to its preneoplastic potential.
    Navarro-Dourdil M; Charro-Calvillo M; Uribarrena-Amézaga R; Sebastián-Domingo JJ
    Hepatogastroenterology; 2014; 61(133):1241-5. PubMed ID: 25436290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Another strike against esophagectomy for high-grade dysplasia in Barrett's esophagus?
    Wani S; Sharma P
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):128-9. PubMed ID: 18237863
    [No Abstract]   [Full Text] [Related]  

  • 34. Optical coherence tomography in Barrett's esophagus: the road to clinical utility.
    Peery AF; Shaheen NJ
    Gastrointest Endosc; 2010 Feb; 71(2):231-4. PubMed ID: 20152306
    [No Abstract]   [Full Text] [Related]  

  • 35. Partial regression of Barrett's esophagus--an inadequate endpoint.
    Sampliner RE; Fass R
    Am J Gastroenterol; 1993 Dec; 88(12):2092-4. PubMed ID: 8249978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Esophageal cancer: epidemiology, pathogenesis and prevention.
    Nat Clin Pract Gastroenterol Hepatol; 2008 Sep; 5(9):517-26. PubMed ID: 18679388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barrett's esophagus and adenocarcinoma risk: the experience of the North-Eastern Italian Registry (EBRA).
    Rugge M; Zaninotto G; Parente P; Zanatta L; Cavallin F; Germanà B; Macrì E; Galliani E; Iuzzolino P; Ferrara F; Marin R; Nisi E; Iaderosa G; Deboni M; Bellumat A; Valiante F; Florea G; Della Libera D; Benini M; Bortesi L; Meggio A; Zorzi MG; Depretis G; Miori G; Morelli L; Cataudella G; d'Amore ES; Franceschetti I; Bozzola L; Paternello E; Antonini C; Di Mario F; Dal Bò N; Furlanetto A; Norberto L; Polese L; Iommarini S; Farinati F; Battaglia G; Diamantis G; Realdon S; Guido E; Mastropaolo G; Canova D; Guerini A; Franceschi M; Zirillo M
    Ann Surg; 2012 Nov; 256(5):788-94; discussion 794-5. PubMed ID: 23095623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further studies on the musculo-fibrous anomaly of the Barrett's mucosa in esophageal carcinomas.
    Rubio CA; Aberg B
    Pathol Res Pract; 1991 Dec; 187(8):1009-13. PubMed ID: 1792182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of Barrett's neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study.
    Vieth M; Schubert B; Lang-Schwarz K; Stolte M
    Endoscopy; 2006 Dec; 38(12):1201-5. PubMed ID: 17163319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controversies of the cardiac mucosa and Barrett's oesophagus.
    Lombard C
    Histopathology; 2006 Jul; 49(1):97-8; author reply 98. PubMed ID: 16842257
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.